OSR (OSRH) Competitors $0.62 +0.01 (+1.66%) As of 09/12/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock OSRH vs. PSTV, MLSS, MDAI, GUTS, ZYXI, WOK, NEPH, NMTC, MODD, and ECORShould you be buying OSR stock or one of its competitors? The main competitors of OSR include Plus Therapeutics (PSTV), Milestone Scientific (MLSS), Spectral AI (MDAI), Fractyl Health (GUTS), Zynex (ZYXI), WORK Medical Technology Group (WOK), Nephros (NEPH), NeuroOne Medical Technologies (NMTC), Modular Medical (MODD), and electroCore (ECOR). These companies are all part of the "medical equipment" industry. OSR vs. Its Competitors Plus Therapeutics Milestone Scientific Spectral AI Fractyl Health Zynex WORK Medical Technology Group Nephros NeuroOne Medical Technologies Modular Medical electroCore OSR (NASDAQ:OSRH) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment. Which has stronger earnings and valuation, OSRH or PSTV? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOSRN/AN/A-$2.41MN/AN/APlus TherapeuticsN/AN/A-$12.98M-$2.24-0.20 Does the media favor OSRH or PSTV? In the previous week, OSR had 3 more articles in the media than Plus Therapeutics. MarketBeat recorded 6 mentions for OSR and 3 mentions for Plus Therapeutics. Plus Therapeutics' average media sentiment score of 0.50 beat OSR's score of 0.27 indicating that Plus Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OSR 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Plus Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, OSRH or PSTV? OSR has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500. Comparatively, Plus Therapeutics has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Do analysts recommend OSRH or PSTV? Plus Therapeutics has a consensus target price of $7.88, indicating a potential upside of 1,660.56%. Given Plus Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Plus Therapeutics is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Plus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is OSRH or PSTV more profitable? OSR has a net margin of 0.00% compared to Plus Therapeutics' net margin of -357.85%. Plus Therapeutics' return on equity of 0.00% beat OSR's return on equity.Company Net Margins Return on Equity Return on Assets OSRN/A -12.19% -8.18% Plus Therapeutics -357.85%N/A -117.72% Do insiders and institutionals believe in OSRH or PSTV? 55.3% of OSR shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 60.6% of OSR shares are owned by company insiders. Comparatively, 0.8% of Plus Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryOSR beats Plus Therapeutics on 7 of the 13 factors compared between the two stocks. Get OSR News Delivered to You Automatically Sign up to receive the latest news and ratings for OSRH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSRH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSRH vs. The Competition Export to ExcelMetricOSRUNCLASSIFIED IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$13.17M$178.98M$2.55B$10.14BDividend YieldN/AN/A2.51%4.59%P/E RatioN/A2.0726.2825.93Price / SalesN/A44.44112.42198.13Price / CashN/A71.5449.2160.44Price / Book-0.1657.2634.656.29Net Income-$2.41M-$1.39M$16.40M$270.77M7 Day Performance7.84%0.83%1.79%3.88%1 Month Performance10.52%-0.20%3.63%4.88%1 Year PerformanceN/A83.32%34.18%26.01% OSR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSRHOSRN/A$0.62+1.7%N/AN/A$13.17MN/A0.00N/APSTVPlus Therapeutics3.236 of 5 stars$0.49+9.3%$7.88+1,502.6%-68.7%$48.78MN/A-0.2220Short Interest ↑MLSSMilestone Scientific2.6829 of 5 stars$0.62-0.5%$1.25+102.6%-38.2%$48.75M$9.08M-8.8130Positive NewsShort Interest ↓Gap DownMDAISpectral AI2.9261 of 5 stars$1.82-0.5%$3.50+92.3%+49.2%$48.65M$29.58M-2.6483GUTSFractyl Health2.1202 of 5 stars$0.92+2.6%$6.53+608.0%-64.3%$46.41M$90K-0.45102ZYXIZynex2.4725 of 5 stars$1.49flat$4.90+228.9%-81.2%$45.14M$192.35M-1.59770Positive NewsWOKWORK Medical Technology GroupN/A$0.78flatN/A-84.5%$44.46M$11.51M0.00226News CoveragePositive NewsNEPHNephros3.2 of 5 stars$3.83-4.0%$5.50+43.6%+127.2%$40.60M$14.16M31.9230Short Interest ↓NMTCNeuroOne Medical Technologies2.6484 of 5 stars$0.79+8.5%$1.45+82.9%+7.2%$39.64M$3.45M-5.2820Analyst ForecastHigh Trading VolumeMODDModular Medical1.2564 of 5 stars$0.72+1.1%N/A-65.8%$39.59MN/A-1.4020News CoverageGap UpECORelectroCore2.0641 of 5 stars$4.89-0.8%$25.50+421.5%-19.0%$37.08M$27.70M-3.0250Gap Down Related Companies and Tools Related Companies Plus Therapeutics Alternatives Milestone Scientific Alternatives Spectral AI Alternatives Fractyl Health Alternatives Zynex Alternatives WORK Medical Technology Group Alternatives Nephros Alternatives NeuroOne Medical Technologies Alternatives Modular Medical Alternatives electroCore Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSRH) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OSR Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OSR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OSRH Stock Alerts